Bill
HB 7027
HB 7027 creates a Florida framework for hemp consumable THC products, requiring independent lab testing, COAs, scannable labeling, child-safe packaging, and delivery rules.
Status / Purpose
- Introduced: February 20, 2025 (sponsors: Salzman, Trabulsy).
- Stated purpose: establish a regulatory framework for “hemp consumable THC products” sold, delivered, or distributed in Florida — including definitions, testing, packaging/labeling, delivery rules, prohibitions near schools, and enforcement tools.
- Procedural note: the bill moved through Housing, Agriculture & Tourism, Budget, and Commerce committees and was placed on the House Second Reading calendar. The provided legislative-action list includes both “Died on Second Reading Calendar (6/16/2025)” and later entries indicating enactment (Public Act 25‑146 and Governor’s signature). These items conflict; the bill text and committee reports described below are drawn from the committee substitute versions provided.
Key definitions (selected)
- “Hemp consumable THC product”: any substance intended for ingestion or inhalation that contains more than trace amounts of cannabinoids (including psychotropic cannabinoids) derived from hemp or other sources, excluding controlled substances and certain FDA‑GRAS seed ingredients or medical marijuana under current law.
- “Psychotropic cannabinoid”: any cannabinoid that causes or may cause psychotropic effects; examples listed include delta‑8 THC, delta‑10 THC, HHC, THC acetate, THCP, THCV, and any others DACS designates.
- “Inhalable”: products consumed through mouth/nasal passages (e.g., cigarettes that contain hemp THC, vapor/aerosol from electronic devices, hemp flower).
- “Independent testing laboratory”: must have no financial interest in tested entities and must be certified as a medical‑marijuana testing lab by the Department of Health or be DACS‑certified as substantially equivalent.
Major requirements and changes
- Testing & Certificate of Analysis (COA)
- Final retail products must be tested by an independent testing lab.
- COA must show testing for cannabinoids, heavy metals, mycotoxins, pesticides, residual solvents, controlled substances, and other contaminants DACS requires.
- COA must confirm total delta‑9‑THC ≤ 0.3% (by tested sample) and that psychotropic cannabinoids do not exceed bill‑specified limits (text provided is truncated; exact numerical limits not included in excerpts).
- Labeling & packaging
- Retail packaging must include a scannable barcode/QR code linking to the COA, product number, website for batch information, expiration date, and milligrams of each marketed cannabinoid per serving.
- Containers must be single‑colored (nontransparent), minimize light/temperature exposure, allow only one logo (≤20% of surface) not attractive to children, and must not include imagery/text suggesting intoxicating effects. (Other child‑appeal restrictions are expanded in committee text.)
- Distribution & sales
- Manufacturers, wholesalers, and retailers must ensure products are tested and labeled per the bill; wholesalers/retailers may rely on manufacturer/wholesaler testing if packaging is unopened and properly tested.
- New rules for delivery sales to consumers were established (details in bill text).
- Prohibitions and enforcement
- Products sold, offered, delivered, or distributed in violation of the program or delivery rules are deemed contraband.
- Ingestion of hemp consumable THC products is prohibited near schools.
- The Division of Alcoholic Beverages (DBPR) is authorized to take actions against tobacco retailer and nicotine product dealer permits for violations.
Fiscal/economic impact
- DACS reported implementation would require $17,199,671 from General Revenue, including funding for 102 FTE positions, 28 vehicles, laboratory capacity, and office/equipment; implementation costs would be addressed in the General Appropriations Act.
Who is affected
- Manufacturers, extractors, wholesalers, and retailers of hemp consumable THC products; independent testing laboratories; consumers; DACS and DBPR (for regulation/enforcement); tobacco/nicotine permittees (subject to permit actions for violations).
Limitations / missing specifics
- The excerpts do not include numeric limits for many psychotropic cannabinoids, specific delivery‑sale operational rules, or penalty schedules. For enforcement thresholds and precise limits, consult the full enrolled bill or final statutory language (if enacted).
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
